I'd invest $5,000 into these excellent ASX shares for the long term

In my opinion, these three ASX shares look like great long-term ideas.

| More on:
A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • If I were given $5,000 to invest in some long-term growth shares, I know of three I’d like to invest in
  • The VanEck Morningstar Wide Moat ETF would be one of my picks because of its quality holdings
  • Lovisa and Sonic Healthcare both have long-term growth potential in my opinion

I think there are some great-looking opportunities on the ASX share market this month. If I had $5,000 to invest into some ASX shares, there are some investments I'd choose for the long term.

While some investors may be fearful of volatility, I think there are advantages to investing at times like this. The most obvious one is that investors can buy businesses at lower prices. I like the sound of that.

In my opinion, choosing a good investment at a good price can lead to good returns over time. You never know what share prices are going to do next, but I want to jump on the opportunities when I see them.

With that in mind, I would spend $5,000 like this:

VanEck Morningstar Wide Moat ETF (ASX: MOAT) — $2,500

This is an exchange-traded fund (ETF) that is based on investing in US businesses that are deemed to have competitive advantages — or 'economic moats' — that are likely to last for many years into the future.

Economic moats can come in many different forms such as intellectual property, brand power, cost advantages, and so on.

Businesses are only chosen for this ETF's portfolio if Morningstar analysts believe the economic moat will stay strong for at least the next decade and, more likely than not, the second decade as well.

On top of that, businesses are only picked for the portfolio if they are good value compared to Morningstar's estimate of fair value.

At the latest disclosure, these are some of the biggest positions in the portfolio: Lockheed Martin, Bristol-Myers Squibb, Altria, Dominion Energy, and Berkshire Hathaway.

I like the idea of this ETF because of the quality across the board that it offers. It also seems to be consistently invested in businesses that are good value because the portfolio changes to the next opportunities.

Lovisa Holdings Ltd (ASX: LOV) – $1,500

Lovisa is a fast-growing ASX share that sells affordable jewellery in multiple countries. The USA is a particularly promising market for the company, which is why it's working on expanding its store network there.

The business appears to be very scalable, which bodes well for future profitability. In the FY22 half-year result, Lovisa reported that it grew its revenue by 48.3%, while net profit after tax (NPAT) increased by 70.3%.

I think that this ASX share has a compelling future under the new management. There are plenty of other regions that Lovisa can expand to, such as countries in Asia, which will lengthen its growth runway.

Another benefit to the company is that it pays dividends, so shareholders are getting the benefit of the profit generated in the form of cash returns.

I think this ASX share can achieve good compounding for years to come.

Sonic Healthcare Limited (ASX: SHL) – $1,000

Sonic Healthcare is a leading company in the pathology sector. It generates profit from Australia, Europe, and the US – it's globally diversified.

The company benefits from long-term trends such as aging demographics. This is helping it achieve steadily-rising revenue and profit. I like that the business is quite defensive – people need healthcare whether the economy is booming or stuttering.

Sonic Healthcare is also benefiting from the ongoing level of COVID-19 testing. It has been an important player in helping slow the spread of the pandemic. It has made plenty of cash flow from testing, which the company has been putting towards acquisitions to boost long-term earnings. Canberra Imaging is one example of a recent acquisition.

I'm attracted to the ASX share's long-term future, even if it hasn't fallen as much as some other ASX shares in 2022.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway (B shares) and Bristol Myers Squibb. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Dominion Energy, Inc and Lockheed Martin and has recommended the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Berkshire Hathaway (B shares), Lovisa Holdings Ltd, Sonic Healthcare Limited, and VanEck Vectors Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Scared looking people on a rollercoaster ride representing volatility.
Opinions

Is it time to be fearful or greedy with ASX shares?

It’s a volatile time for the stock market. What should investors do?

Read more »

Interest rates written on top of pictures of houses on a computer.
Opinions

If the RBA cuts rates 5 times in 2025, I'd definitely want to buy these ASX shares today

Could the central bank need to swoop in to save the economy?

Read more »

tick, approval, business person with device and tick of approval in background
Opinions

The Warren Buffett seal of approval: If the stock market closed for 10 years, I'd happily own this quality ASX 200 stock

I’d be happy to hold this ASX 200 stock for 10-plus years, in line with Warren Buffett’s advice.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Opinions

Many ASX share prices are falling today. How do I decide what to buy?

April 2025 has started off roughly. What should we buy?

Read more »

An Australian farmer wearing a beaten-up akubra hat and work shirt leans on a fence with livestock in the background and a blue sky above.
Opinions

Why it could be a great time to buy this high-yield ASX stock

I think this business could be a fertile option for returns.

Read more »

a water tap is turned on and showering out banknotes into the open hand of a woman below it.
Opinions

I think this ASX small-cap stock is a bargain at $1.43

This small stock could make a big splash.

Read more »

share buyers, investors, happy investors
Opinions

I'm going to make this ASX 200 share my next investment

I think this ASX share looks like a fantastic opportunity today.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

Why the ASX share market tariff sell-off can accelerate your wealth

There’s a silver lining to this sell-off.

Read more »